Skip to main content
Erschienen in: Current Reviews in Musculoskeletal Medicine 3/2011

01.09.2011

Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments

verfasst von: Cindy H. Flower, Anselm J. M. Hennis, Matthew H. Liang

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Disparities in health outcomes occur in systemic lupus erythematosus (SLE) especially in economically disadvantaged populations. At the 9th International Congress on SLE, June 24–27, 2010, held in Vancouver, British Columbia, a symposium “Narrowing the Gap in the Treatment and Study of SLE worldwide” was held. Participating physicians from the Caribbean, Central and South America, Asia, Portugal, Africa and impoverished areas of the United States detailed their constraints and desires. These were remarkably consistent. Out of these discussions, a statement on minimum best practice was put forth aimed at the cost-effective management of SLE focusing on the critical factors that make a difference and are feasible even in the most challenging environments. Approaches to designing studies and establishing research and mentoring collaborations was also discussed. The ultimate aim was to provide an avenue for the improvement of care and outcomes for patients with SLE worldwide.
Literatur
1.
Zurück zum Zitat McCarty DJ, Manzi S. jr et al. Incidence of SLE: race and gender differences. Arthritis Rheum. 1995;38:1260–70.PubMedCrossRef McCarty DJ, Manzi S. jr et al. Incidence of SLE: race and gender differences. Arthritis Rheum. 1995;38:1260–70.PubMedCrossRef
2.
Zurück zum Zitat Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 2002;11:161–7.PubMedCrossRef Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 2002;11:161–7.PubMedCrossRef
3.
Zurück zum Zitat D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet. 2007;369:587–96.PubMedCrossRef D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet. 2007;369:587–96.PubMedCrossRef
4.
Zurück zum Zitat Peschken CA, Esdaile JM. Systemic lupus erythematosus in north American Indians: a population based study. J Rheumatol. 2000;27:1884–91.PubMed Peschken CA, Esdaile JM. Systemic lupus erythematosus in north American Indians: a population based study. J Rheumatol. 2000;27:1884–91.PubMed
5.
Zurück zum Zitat Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol. 1995;22:1663–8.PubMed Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol. 1995;22:1663–8.PubMed
6.
Zurück zum Zitat Walsh SJ, Algert C, Rothfield NF. Racial aspects of comorbidity in systemic lupus erythematosus. Arth Care Res. 1996;96:509–16.CrossRef Walsh SJ, Algert C, Rothfield NF. Racial aspects of comorbidity in systemic lupus erythematosus. Arth Care Res. 1996;96:509–16.CrossRef
7.
Zurück zum Zitat Liang MH, Partridge AJ, Daltroy LH, et al. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum. 1991;34:1187–96.PubMedCrossRef Liang MH, Partridge AJ, Daltroy LH, et al. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum. 1991;34:1187–96.PubMedCrossRef
8.
Zurück zum Zitat Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis. 2006;65:1500–5.PubMedCrossRef Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis. 2006;65:1500–5.PubMedCrossRef
9.
Zurück zum Zitat CDC Trends in Deaths from Systemic Lupus Erythematosus- United States. 1979–1998. MMVR. 2002;51:371–3. CDC Trends in Deaths from Systemic Lupus Erythematosus- United States. 1979–1998. MMVR. 2002;51:371–3.
10.
Zurück zum Zitat Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol. 1985;14:43–6.PubMedCrossRef Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol. 1985;14:43–6.PubMedCrossRef
11.
Zurück zum Zitat Hochberg MC. Mortality from systemic lupus erythematosus in England and Wales, 1974–1983. Br J Rheumatol. 1987;26:437–41.PubMedCrossRef Hochberg MC. Mortality from systemic lupus erythematosus in England and Wales, 1974–1983. Br J Rheumatol. 1987;26:437–41.PubMedCrossRef
12.
Zurück zum Zitat Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–7.PubMedCrossRef Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–7.PubMedCrossRef
13.
Zurück zum Zitat • Ippolito A, Petri M. An update on mortality in Systemic Lupus Erythematosus. Clin Exp Rheumatol 2008; 26 (Suppl:51) S72-S79 article reports the over 90% 10 year survival rate for SLE in USA and Europe with disparities in mortality worldwide based on socioeconomics, age, gender, ethnicity. PubMed • Ippolito A, Petri M. An update on mortality in Systemic Lupus Erythematosus. Clin Exp Rheumatol 2008; 26 (Suppl:51) S72-S79 article reports the over 90% 10 year survival rate for SLE in USA and Europe with disparities in mortality worldwide based on socioeconomics, age, gender, ethnicity. PubMed
14.
Zurück zum Zitat Wadee S, Tikly M, Hopley M. Causes and predictors of death in south Africans with systemic lupus erythematosus. Rheumatol Oxf. 2007;46:1487–91.CrossRef Wadee S, Tikly M, Hopley M. Causes and predictors of death in south Africans with systemic lupus erythematosus. Rheumatol Oxf. 2007;46:1487–91.CrossRef
15.
Zurück zum Zitat Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis. 1992;51:1197–201.PubMedCrossRef Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis. 1992;51:1197–201.PubMedCrossRef
16.
Zurück zum Zitat • Vasudevan A, Krishnamurthy AN. Changing worldwide epidemiology of systemic lupus erythematosus. Rheum Dis Clin N Am 2010; 36: 1–13 article reports that the poorer outcomes in developing countries compared to developed countries is likely a combination of economic issues, health care access, physician availability, education, compliance. CrossRef • Vasudevan A, Krishnamurthy AN. Changing worldwide epidemiology of systemic lupus erythematosus. Rheum Dis Clin N Am 2010; 36: 1–13 article reports that the poorer outcomes in developing countries compared to developed countries is likely a combination of economic issues, health care access, physician availability, education, compliance. CrossRef
17.
Zurück zum Zitat •• Demas KL, Costenbader KH. Disparities in lupus care and outcomes.Curr Opin Rheumatol. 2009; 21:102–9. Report proposes to address disparities with teams of experienced physicians, educators, caregivers, working with patients, their loved ones to strengthen social support, enhance self-efficacy, decrease comorbidities, increase adherence.PubMedCrossRef •• Demas KL, Costenbader KH. Disparities in lupus care and outcomes.Curr Opin Rheumatol. 2009; 21:102–9. Report proposes to address disparities with teams of experienced physicians, educators, caregivers, working with patients, their loved ones to strengthen social support, enhance self-efficacy, decrease comorbidities, increase adherence.PubMedCrossRef
18.
Zurück zum Zitat Mosca M, Tani C, Aringer M, et al. European league against rheumatism recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis. 2010;69:1269–74.PubMedCrossRef Mosca M, Tani C, Aringer M, et al. European league against rheumatism recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis. 2010;69:1269–74.PubMedCrossRef
19.
Zurück zum Zitat Goldblatt F, Isenberg DA. New therapies for systemic lupus erythematosus. Clin Exp Immunol. 2005;140:205–12.PubMedCrossRef Goldblatt F, Isenberg DA. New therapies for systemic lupus erythematosus. Clin Exp Immunol. 2005;140:205–12.PubMedCrossRef
20.
Zurück zum Zitat Whitelaw D, Jessop S. Chloroquine-induced retinal toxicity. S Afr Med J. 2005;95:72.PubMed Whitelaw D, Jessop S. Chloroquine-induced retinal toxicity. S Afr Med J. 2005;95:72.PubMed
21.
Zurück zum Zitat Ahn YS, Harrington WJ, Seelman RC, et al. Vincristine therapy in idiopathic and secondary thrombocytopenia. N Engl J Med. 1974;291:376–80.PubMedCrossRef Ahn YS, Harrington WJ, Seelman RC, et al. Vincristine therapy in idiopathic and secondary thrombocytopenia. N Engl J Med. 1974;291:376–80.PubMedCrossRef
22.
Zurück zum Zitat Cil T, Altintas A, Tamam Y, et al. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report. J Pediatr hematol Oncol. 2009;31:787–9.PubMedCrossRef Cil T, Altintas A, Tamam Y, et al. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report. J Pediatr hematol Oncol. 2009;31:787–9.PubMedCrossRef
23.
Zurück zum Zitat Salach RH, Cash JM. Managing lupus nephritis: algorithms for conservative use of renal biopsy. Cleve Clin J Med. 1996;63:106–15.PubMed Salach RH, Cash JM. Managing lupus nephritis: algorithms for conservative use of renal biopsy. Cleve Clin J Med. 1996;63:106–15.PubMed
24.
Zurück zum Zitat Houssiau F. Thirty years of cyclophosphamide: assessing the evidence. Lupus. 2007;16:212–6.PubMed Houssiau F. Thirty years of cyclophosphamide: assessing the evidence. Lupus. 2007;16:212–6.PubMed
25.
Zurück zum Zitat Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus. 2007;16:387–93.PubMedCrossRef Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus. 2007;16:387–93.PubMedCrossRef
26.
Zurück zum Zitat Isenberg D. Thirty-five years, five hundred patients: some lessons learned from running a lupus clinic. Lupus. 2010;19:667–74.PubMedCrossRef Isenberg D. Thirty-five years, five hundred patients: some lessons learned from running a lupus clinic. Lupus. 2010;19:667–74.PubMedCrossRef
27.
Zurück zum Zitat Gawande A. Complications: A surgeon’s notes on an imperfect science. Picador Press, 2003, p 1–269. Gawande A. Complications: A surgeon’s notes on an imperfect science. Picador Press, 2003, p 1–269.
28.
Zurück zum Zitat American College of Rheumatology Ad hoc Committee on systemic lupus erythematosus. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785–96.CrossRef American College of Rheumatology Ad hoc Committee on systemic lupus erythematosus. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785–96.CrossRef
29.
Zurück zum Zitat Trupin L, Tonner MC, Yazdany J, et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. Rheumatol. 2008;35:1782–8. Trupin L, Tonner MC, Yazdany J, et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. Rheumatol. 2008;35:1782–8.
30.
Zurück zum Zitat Syarief DW. How to make friends with lupus. Lupus. 2010;19(1S):167 Syarief DW. How to make friends with lupus. Lupus. 2010;19(1S):167
31.
Zurück zum Zitat Klippel JH, DieppePA, editors. Rheumatology. London Mosby; 1998. Klippel JH, DieppePA, editors. Rheumatology. London Mosby; 1998.
32.
Zurück zum Zitat Petri M. Epidemiology of systemic lupus erythematosus. Clin Rheumatol. 2002;16:847–58. Petri M. Epidemiology of systemic lupus erythematosus. Clin Rheumatol. 2002;16:847–58.
33.
Zurück zum Zitat Flower C, Hennis A, Hambleton IR, et al. Lupus nephritis in an afro-Caribbean population: renal indices and clinical outcomes. Lupus. 2006;15:689–94.PubMedCrossRef Flower C, Hennis A, Hambleton IR, et al. Lupus nephritis in an afro-Caribbean population: renal indices and clinical outcomes. Lupus. 2006;15:689–94.PubMedCrossRef
34.
Zurück zum Zitat Faurschou M, Starklint H, Halberg P, et al. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006;33:689–94. Faurschou M, Starklint H, Halberg P, et al. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006;33:689–94.
35.
Zurück zum Zitat Sakdisthanont S, Siripul P. Self-management in Thai adolescents with systemic lupus erythematosus. Lupus. 2010;19(1S):166. Sakdisthanont S, Siripul P. Self-management in Thai adolescents with systemic lupus erythematosus. Lupus. 2010;19(1S):166.
36.
Zurück zum Zitat Yazdany J, Yelin EN, Panopalis P, et al. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum. 2008;59:136–43.PubMedCrossRef Yazdany J, Yelin EN, Panopalis P, et al. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum. 2008;59:136–43.PubMedCrossRef
37.
Zurück zum Zitat Costenbader KH, Khamashta M, Ruiz-Garcia S, et al. Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res Hoboken. 2010;62:559–68.PubMedCrossRef Costenbader KH, Khamashta M, Ruiz-Garcia S, et al. Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res Hoboken. 2010;62:559–68.PubMedCrossRef
38.
Zurück zum Zitat Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire (CSQ) for population studies. Ann Epidemiol. 1995;5:297–302.PubMedCrossRef Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire (CSQ) for population studies. Ann Epidemiol. 1995;5:297–302.PubMedCrossRef
Metadaten
Titel
Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments
verfasst von
Cindy H. Flower
Anselm J. M. Hennis
Matthew H. Liang
Publikationsdatum
01.09.2011
Verlag
Current Science Inc.
Erschienen in
Current Reviews in Musculoskeletal Medicine / Ausgabe 3/2011
Elektronische ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-011-9080-0

Weitere Artikel der Ausgabe 3/2011

Current Reviews in Musculoskeletal Medicine 3/2011 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Lever-Sign-Test hilft beim Verdacht auf Kreuzbandriss

15.05.2024 Vordere Kreuzbandruptur Nachrichten

Mit dem Hebelzeichen-Test lässt sich offenbar recht zuverlässig feststellen, ob ein vorderes Kreuzband gerissen ist. In einer Metaanalyse war die Vorhersagekraft vor allem bei positivem Testergebnis hoch.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.